Clinical Trial

Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)

Recruiting
View on ClinicalTrials.gov →
Summary
(SINGLE SITE Study) The purpose of this clinical trial is to evaluate the safety and efficacy of the use of an autologous hair follicle derived secretome for androgenous alopecia. The secretome will be injected into the scalp at baseline, and days 30, 90, 180, 270 and 365. Hair growth will be quantitatively measured for density and thickness. PROs will also be collected from participants. This study will be run at a SINGLE SITE.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-08-05; most recent amendment 2026-02-10.
Status change: Not Yet Recruiting → Recruiting 2025-10-16
Trial Details
NCT Number NCT07107841
Lead Sponsor Acorn Biolabs Inc.
Conditions Androgenic Alopecia, Alopecia, Baldness
Enrollment 60 participants
Start Date 2025-10-16
Primary Completion 2027-09-15 (estimated)
Study Completion 2027-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-12